REFERENCES
- Koopman J, van der Heiden-van der Loo M, van Dijk M, Bijlsma W. Incidence of primary malignant orbital tumours in the Netherlands. Eye 2011;25(4):461–4465.
- Dong-Eun O, Yoon-Duck K. Lymphoproliferative Diseases of the ocular adnexa in korea. ArchOphthalmol 2007;125(12):1668–1673.
- Kantarjian H, Thomas D, O’Brien S, Cortes J, Giles F, Jeha S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 2004;101(12):2788–2801.
- Pasricha SR, Grigg A, Catalano J, Leahy M, Underhill C, Arthur C, et al. A multicenter phase 2 study of risks-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma. Cancer 2008;113(11):3192–3198.
- Tripodo C, Lannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, et al. Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 2009;6(12):707–717.
- Belhadji K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003;102(13):4261–4269.